Fish Oil-Supplemented Parenteral Nutrition in Severe Acute Pancreatitis Patients and Effects on Immune Function and Infectious Risk: A Randomized Controlled Trial

Bradley, E. L. 1993. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch. Surg. 128:586–590.

Denham, W., and J. Norman. 1999. The potential role of therapeutic cytokine manipulation in acute pancreatitis. Surg. Clin. North Am. 79:767–781.

Hughes, C. B., H. P. Grewal, L. W. Gaber, et al. 1996. Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am. J. Surg. 17:274–280.

Kingsnorth, A. N., S. W. Galloway, and L. J. Formela. 1995. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br. J. Surg. 82:1414–1420.

Foitzik, T., G. Eibl, H. G. Hotz, J. Faulhaber, M. Kirchengast, and H. J. Buhr. 2000. Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates. Surgery 128:399–407.

Weiss, G., F. Meyer, B. Matthies, M. Pross, W. Koenig, and H. Lippert. 2002. Immunomodulation by perioperative administration of n−3 fatty acids. Br. J. Nutr. 87:S89–S94.

Mayer, K., S. Meyer, M. Reinholz-Muhly, et al. 2003. Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J. Immunol. 171:4837–4843.

Alhan, E., S. Turkyilmaz, C. Ercin, N. Kaklikkaya, and B. V. Kural. 2006. Effects of omega-3 fatty acids on acute necrotizing pancreatitis in rats. Eur. Surg. Res. 38:314–321.

Foitzik, T., G. Eibl, P. Schneider, F. A. Wenger, C. A. Jacobi, and H. J. Buhr. 2002. Omega-3 fatty acid supplementation increases anti-inflammatory cytokines and attenuates systemic disease sequelae in experimental pancreatitis. JPEN. 26:351–356.

Axel, R., S. R. Heller, R. J. Litz, et al. 2006. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit. Care Med. 34:972–979.

Tsekos, E., C. Reuter, P. Stehle, and G. Boeden. 2004. Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin. Nutr. 23:325–330.

Beale, R. J., D. J. Bryg, and D. J. Bihari. 1999. Immunonutrition in the critically ill: a systemic review of clinical outcome. Crit. Care Med. 27:2799–2805.

Lee, J. Y., K. H. Sohn, S. H. Rhee, and D. Hwang. 2001. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4. J. Biol. Chem. 276:16683–16689.

Rau, B. M., C. M. Krüger, C. Hasel, et al. 2006. Effects of immunosuppressive and immunostimulative treatment on pancreatic injury and mortality in severe acute experimental pancreatitis. Pancreas 33:174–183.

Pezzilli, R., R. Ceciliato, B. Barakat, and R. Corinaldesi. 2004. Immune-manipulation of the inflammatory response in acute pancreatitis. What can be expected. JOP. 5:115–121.

Ong, E., A. Kurland, D. Jho, T. A. Babcock, and N. Espat. 2004. n−3 Fatty acids but NOT COX-2 inhibitor treatment is antiinflammatory in the lungs of tumor bearing rats independent of protein kinase B (Akt) activity. Ann. Surg. Oncol. 11:S124.

Pacht, E. R., S. J. DeMichele, J. L. Nelson, J. Hart, A. K. Wennberg, and J. E. Gadek. 2003. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit. Care Med. 31:491–500.

Gadek, J. E., S. J. DeMichele, M. D. Karlstad, et al. 1999. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit. Care Med. 27:1409–1420.

Bone, R. C. 1996. Sir Isaac Newton. Sepsis, SIRS and CARS. Crit. Care Med. 24:1125–1128.

Döcke, W. D., F. Randow, U. Syrbe, et al. 1997. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med. 3:678–681.

Kox, W. J., R. C. Bone, D. Krausch, et al. 1997. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle. Arch. Intern. Med. 157:389–393.

Solomkin, J. S., M. K. Jenkins, R. D. Nelson, D. Chenoweth, and R. L. Simmons. 1981. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Surgery 90:319–327.

Solomkin, J. S., L. A. Cotta, J. K. Brodt, J. W. Hurst, and C. K. Ogle. 1984. Neutrophil dysfunction in sepsis. III. Degranulation as a mechanism for nonspecific deactivation. J. Surg. Res. 36:407–412.

Sorrell, T. C., K. Sztelma, and G. L. May. 1994. Circulating polymorphonuclear leukocytes from patients with gram-negative bacteremia are not primed for enhanced production of leukotriene B4 or 5-hydroxyeicosatetraenoic acid. J. Infect. Dis. 169:1151–1154.

Garcia-Garmendia, J. L., J. Garnacho-Montero, C. Ortiz-Leyba, et al. 1998. Cytokine levels in critically-ill septic patients fed with an enteral diet supplemented with fish oil and vitamin E. Clin. Nutr. 17:6.

Rongione, A. J., A. M. Kusske, K. Kwan, et al. 1997. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 112:960–967.

Gazzinelli, R. T., I. P. Oswald, S. L. James, et al. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gammaactivated macrophages. J. Immunol. 148:1792–1796.

Pradier, O., C. Gerard, C. Delvaux, et al. 1993. Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur. J. Immunol. 23:2700–2703.

Howard, M., T. Muchamuel, S. Andrade, et al. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205–1208.